"4"^^ . . "Stanoven\u00ED obsahu a rychlosti uvol\u0148ov\u00E1n\u00ED ciclopiroxolaminu z mukoadhezivn\u00EDch or\u00E1ln\u00EDch tablet vzhledem k citlivosti kvasinek rodu Candida"@cs . "1"^^ . "Rabi\u0161kov\u00E1, M." . "Ma\u0161ek, Josef" . "59" . . "Or\u00E1ln\u00ED kandid\u00F3zy p\u0159edstavuj\u00ED u imunodeficientn\u00EDch pacient\u016F obt\u00ED\u017En\u011B l\u00E9\u010Ditelnou komplikaci s \u010Dast\u00FDmi recidivami. Mukoadhezivn\u00ED or\u00E1ln\u00ED tablety s prodlou\u017Een\u00FDm uvol\u0148ov\u00E1n\u00EDm lok\u00E1ln\u011B p\u016Fsob\u00EDc\u00EDho antimykotika, nap\u0159. ciclopiroxolaminu, by mohly p\u0159isp\u011Bt k jejich farmakoterapii. Pro efektivn\u00ED terapii je nutn\u00E9 stanovit koncentraci l\u00E9\u010Diva, kter\u00E1 mus\u00ED b\u00FDt v \u00FAstn\u00ED dutin\u011B zachov\u00E1na, tj. zjistit obsah v l\u00E9kov\u00E9 form\u011B a rychlost uvol\u0148ov\u00E1n\u00ED l\u00E9\u010Div\u00E9 l\u00E1tky z n\u00ED. Pr\u00E1ce se v teoretick\u00E9 \u010D\u00E1sti zab\u00FDv\u00E1 z\u00E1kladn\u00ED charakteristikou kvasinek rodu Candida a jimi vyvol\u00E1van\u00FDmi or\u00E1ln\u00EDmi kandid\u00F3zami, mo\u017Enostmi pou\u017Eit\u00ED standardizovan\u00FDch metod k jejich pr\u016Fkazu a stanoven\u00ED citlivosti na antimykotika. Experiment\u00E1ln\u00ED \u010D\u00E1st se zam\u011B\u0159uje na pr\u016Fkaz, identifikaci a kvantifikaci zastoupen\u00ED druhu Candida u pacient\u016F pomoc\u00ED kultivace na chromogenn\u00EDm agaru. U izolovan\u00FDch i referen\u010Dn\u00EDch kmen\u016F kvasinek byla pomoc\u00ED mikrodilu\u010Dn\u00ED a diskov\u00E9 difuzn\u00ED metody hodnocena citlivost na l\u00E9\u010Divo ciclopiroxolamin."@cs . "CZ - \u010Cesk\u00E1 republika" . "RIV/00027162:_____/10:#0000663!RIV11-MZE-00027162" . "Or\u00E1ln\u00ED kandid\u00F3zy p\u0159edstavuj\u00ED u imunodeficientn\u00EDch pacient\u016F obt\u00ED\u017En\u011B l\u00E9\u010Ditelnou komplikaci s \u010Dast\u00FDmi recidivami. Mukoadhezivn\u00ED or\u00E1ln\u00ED tablety s prodlou\u017Een\u00FDm uvol\u0148ov\u00E1n\u00EDm lok\u00E1ln\u011B p\u016Fsob\u00EDc\u00EDho antimykotika, nap\u0159. ciclopiroxolaminu, by mohly p\u0159isp\u011Bt k jejich farmakoterapii. Pro efektivn\u00ED terapii je nutn\u00E9 stanovit koncentraci l\u00E9\u010Diva, kter\u00E1 mus\u00ED b\u00FDt v \u00FAstn\u00ED dutin\u011B zachov\u00E1na, tj. zjistit obsah v l\u00E9kov\u00E9 form\u011B a rychlost uvol\u0148ov\u00E1n\u00ED l\u00E9\u010Div\u00E9 l\u00E1tky z n\u00ED. Pr\u00E1ce se v teoretick\u00E9 \u010D\u00E1sti zab\u00FDv\u00E1 z\u00E1kladn\u00ED charakteristikou kvasinek rodu Candida a jimi vyvol\u00E1van\u00FDmi or\u00E1ln\u00EDmi kandid\u00F3zami, mo\u017Enostmi pou\u017Eit\u00ED standardizovan\u00FDch metod k jejich pr\u016Fkazu a stanoven\u00ED citlivosti na antimykotika. Experiment\u00E1ln\u00ED \u010D\u00E1st se zam\u011B\u0159uje na pr\u016Fkaz, identifikaci a kvantifikaci zastoupen\u00ED druhu Candida u pacient\u016F pomoc\u00ED kultivace na chromogenn\u00EDm agaru. U izolovan\u00FDch i referen\u010Dn\u00EDch kmen\u016F kvasinek byla pomoc\u00ED mikrodilu\u010Dn\u00ED a diskov\u00E9 difuzn\u00ED metody hodnocena citlivost na l\u00E9\u010Divo ciclopiroxolamin." . "\u010Cesk\u00E1 a slovensk\u00E1 farmacie" . . . "Gajdziok, J." . "candida; antifungal drug; ciclopiroxolamine; mucoadhesive dosage form; local therapy"@en . "289751" . "[81E2E7D5CAFB]" . . "Stanoven\u00ED obsahu a rychlosti uvol\u0148ov\u00E1n\u00ED ciclopiroxolaminu z mukoadhezivn\u00EDch or\u00E1ln\u00EDch tablet vzhledem k citlivosti kvasinek rodu Candida"@cs . "RIV/00027162:_____/10:#0000663" . "Stanoven\u00ED obsahu a rychlosti uvol\u0148ov\u00E1n\u00ED ciclopiroxolaminu z mukoadhezivn\u00EDch or\u00E1ln\u00EDch tablet vzhledem k citlivosti kvasinek rodu Candida" . . "Ma\u0161kov\u00E1, E." . "Oral candidosis represent difficult and often recidiving complication in immunodeficient patients. Oral mucoadhesive tablets with prolonged release of localy acting antifungal drug, e.g. ciclopiroxolamine, could contribute to their pharmacotherapy. For efficient therapy, the drug concentration present in oral cavity has to be determined, i.e. the drug content in dosage form and its release have to be formed. Theoretical part of this work is aimed to the basic characteristics of Candida yeasts and their induction of oral candidosis, to the possibilities of using standardized methods for detecting and determining their susceptibility to antifungal agents. Experimental part is focused on the establishment, identification and quantification of Candida species represented in patients by cultivation on chromogenic agar. The microdilution and disk diffusion methods have been used for assessing the susceptibility of isolated and reference strains of yeasts to antifungal drug - ciclopiroxolamine."@en . . "Determination of ciclopiroxolamine content and its release rate from oral mucoadhesive tablets concerning Candida yeasts susceptibility"@en . . "Determination of ciclopiroxolamine content and its release rate from oral mucoadhesive tablets concerning Candida yeasts susceptibility"@en . . "2" . . . . . "Z(MZE0002716202)" . . "8"^^ . "Stanoven\u00ED obsahu a rychlosti uvol\u0148ov\u00E1n\u00ED ciclopiroxolaminu z mukoadhezivn\u00EDch or\u00E1ln\u00EDch tablet vzhledem k citlivosti kvasinek rodu Candida" . "1210-7816" . . . .